Fresenius 6-K Q1 2003
Table of Contents

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934

For the month of May 2003

FRESENIUS MEDICAL CARE CORPORATION
(Translation of registrant’s name into English)

Else-Kröner Strasse 1
61346 Bad Homburg
Germany
(Address of principal executive offices)

     Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

     Form 20-F [X]       Form 40-F [  ]

     Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):        

     Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):        

     Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

     Yes [  ]       No [X]

     If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82

 


TABLE OF CONTENTS

EXHIBITS
SIGNATURES
EX-99.1


Table of Contents

EXHIBITS

     
Exhibit 99.1   Earnings press release dated May 7, 2003

2


Table of Contents

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

DATE: May 7, 2003

     
     
     
  Fresenius Medical Care
Aktiengesellschaft
     
     
  By: /s/ Dr. Ben Lipps
   
    Name: Dr. Ben Lipps
Title:   Chairman of the Management Board
     
     
  By: /s/ Dr. Ulf M. Schneider
   
    Name: Dr. Ulf M. Schneider
Title:   Chief Financial Officer

3